ARROWHEAD PHARMACEUTICALS IN

Ticker: ARWR CUSIP: 04280A100 Class: Common Stock

SILVERCREST ASSET MANAGEMENT GROUP LLC's Holding History (CIK: 0001232395)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 158,622 Value ($000) $10,531 Avg Close $49.01 Range $34.38 - $72.36
Q3 2025
Shares 272,974 Value ($000) $9,415 Avg Close $21.98 Range $14.30 - $34.61
Q2 2025
Shares 280,177 Value ($000) $4,427 Avg Close $14.35 Range $9.57 - $17.49
Q1 2025
Shares 279,749 Value ($000) $3,564 Avg Close $18.18 Range $12.14 - $21.84
Q4 2024
Shares 280,511 Value ($000) $5,274 Avg Close $20.59 Range $17.05 - $27.34
Q3 2024
Shares 224,889 Value ($000) $4,356 Avg Close $24.41 Range $19.07 - $30.41
Q2 2024
Shares 152,259 Value ($000) $3,957 Avg Close $24.57 Range $21.39 - $28.50
Q1 2024
Shares 150,198 Value ($000) $4,296 Avg Close $31.99 Range $27.00 - $39.83
Q4 2023
Shares 100,226 Value ($000) $3,067 Avg Close $26.56 Range $20.67 - $31.68
Q3 2023
Shares 100,279 Value ($000) $2,694 Avg Close $30.63 Range $26.04 - $36.43
Q2 2023
Shares 100,385 Value ($000) $3,580 Avg Close $34.48 Range $24.64 - $42.48
Q1 2023
Shares 85,507 Value ($000) $2,172 Avg Close $31.45 Range $23.09 - $41.03